• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

National List of Essential Medicines in India: A Story of Deprivation of Substance Use Disorder Treatment.

作者信息

Parmar Arpit, Pal Arghya, Sharma Pawan

机构信息

Dept. of Psychiatry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Dept. of Psychiatry, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India.

出版信息

Indian J Psychol Med. 2021 Nov;43(6):531-534. doi: 10.1177/0253717620972942. Epub 2020 Dec 7.

DOI:10.1177/0253717620972942
PMID:35210682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8826205/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb7e/8826205/899f9c5db6ee/10.1177_0253717620972942-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb7e/8826205/899f9c5db6ee/10.1177_0253717620972942-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb7e/8826205/899f9c5db6ee/10.1177_0253717620972942-fig1.jpg

相似文献

1
National List of Essential Medicines in India: A Story of Deprivation of Substance Use Disorder Treatment.印度基本药物目录：物质使用障碍治疗被忽视的情况
Indian J Psychol Med. 2021 Nov;43(6):531-534. doi: 10.1177/0253717620972942. Epub 2020 Dec 7.
2
Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.世界卫生组织、印度、南非和中国基本药物清单：比较研究。
J Evid Based Med. 2017 Nov;10(4):271-280. doi: 10.1111/jebm.12240. Epub 2017 May 24.
3
Comparison of essential drug list in a rural secondary care hospital in south India with Indian & World Health Organization list 2011.印度南部一家农村二级护理医院的基本药物清单与2011年印度及世界卫生组织清单的比较。
Indian J Physiol Pharmacol. 2012 Oct-Dec;56(4):375-81.
4
The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line.《2022年印度基本药物目录》（NLEM 2022）：汤米，循规蹈矩。 （注：这里的“Tommy, Toe the Line”字面意思是“汤米，循规蹈矩” ，放在这个语境中可能有特定含义，但仅按要求翻译字面内容 ）
Lancet Reg Health Southeast Asia. 2023 Apr 24;13:100202. doi: 10.1016/j.lansea.2023.100202. eCollection 2023 Jun.
5
National list of essential medicines of India: the way forward.印度基本药物国家清单：前进之路。
J Postgrad Med. 2012 Jan-Mar;58(1):68-72. doi: 10.4103/0022-3859.93258.
6
Use of drugs not listed in the National List of Essential Medicines: Findings from a prescription analysis by the Indian Council of Medical Research-Rational Use of Medicines Centres Network in tertiary care hospitals across India.未列入国家基本药物目录的药品使用情况：印度医学研究理事会-合理用药中心网络在印度三级保健医院进行的处方分析结果。
Indian J Pharmacol. 2022 Nov-Dec;54(6):407-416. doi: 10.4103/ijp.ijp_878_21.
7
Cost analysis study of neuropsychiatric drugs: Role of National List of Essential Medicines, India.神经精神类药物的成本分析研究：印度《国家基本药物目录》的作用。
Neurol India. 2018 Sep-Oct;66(5):1427-1433. doi: 10.4103/0028-3886.241345.
8
National Essential Medicines List and policy practice: a case study of China's health care reform.国家基本药物目录及政策实践：中国医改案例研究。
BMC Health Serv Res. 2012 Nov 14;12:401. doi: 10.1186/1472-6963-12-401.
9
Factors Affecting the Availability and Utilization of Essential Medicines in India: A Systematic Review.影响印度基本药物可及性和使用情况的因素：一项系统综述
J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1064-S1071. doi: 10.4103/jpbs.jpbs_1198_23. Epub 2024 Apr 16.
10
Availability of Pediatric Formulations in Public Health Care System in India: A Case Study.印度公共医疗体系中儿科制剂的供应情况：案例研究。
Indian J Pediatr. 2021 Mar;88(3):227-234. doi: 10.1007/s12098-020-03220-3. Epub 2020 Feb 21.

引用本文的文献

1
Cost-effectiveness analysis of oral antiviral therapy in patients with indeterminate chronic hepatitis B infection.慢性乙型肝炎感染状态不明患者口服抗病毒治疗的成本效益分析
Transl Gastroenterol Hepatol. 2025 Jul 14;10:43. doi: 10.21037/tgh-24-163. eCollection 2025.
2
Assessment of national tobacco control program (NTCP) initiative on tobacco cessation among transgenders in Puducherry - A quasi-experimental study.对本地治里地区变性者戒烟的国家烟草控制计划（NTCP）倡议的评估——一项准实验研究。
J Family Med Prim Care. 2024 Dec;13(12):5708-5713. doi: 10.4103/jfmpc.jfmpc_881_24. Epub 2024 Dec 9.
3
Advocating for the inclusion of therapeutic drug monitoring in the national essential diagnostic list: Perspectives from psychiatrists.

本文引用的文献

1
What's next for WHO's global strategy to reduce the harmful use of alcohol?世界卫生组织减少有害饮酒全球战略的下一步是什么？
Bull World Health Organ. 2020 Mar 1;98(3):222-223. doi: 10.2471/BLT.19.241737. Epub 2020 Jan 28.
2
National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study.2000 年至 2016 年归因于酒精使用的全球、区域和国家疾病负担：一项比较风险评估研究。
Lancet Public Health. 2020 Jan;5(1):e51-e61. doi: 10.1016/S2468-2667(19)30231-2.
3
Tobacco Use and Tobacco-Related Behaviors - 11 Countries, 2008-2017.
倡导将治疗药物监测纳入国家基本诊断清单：精神科医生的观点。
Indian J Psychiatry. 2024 Jul;66(7):660-664. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_330_24. Epub 2024 Jul 17.
4
A Study of Drug Utilization Pattern and Pharmacoeconomic Analysis of Immunosuppressant Drugs in Patients With Skin Disorders in a Tertiary Care Hospital in Bihar.比哈尔邦一家三级护理医院皮肤病患者免疫抑制剂药物使用模式及药物经济学分析研究
Cureus. 2023 Nov 8;15(11):e48541. doi: 10.7759/cureus.48541. eCollection 2023 Nov.
5
National List of Essential Medicines 2022 of India: Perspectives from Psychiatrists.《2022年印度基本药物目录：精神科医生的观点》
Indian J Psychol Med. 2023 Jul;45(4):411-414. doi: 10.1177/02537176231155328. Epub 2023 Feb 16.
6
List of essential psychotherapeutic medicines 2019 of India: When science was left behind.2019年印度基本心理治疗药物清单：科学被抛诸脑后之时。
Indian J Psychiatry. 2022 Mar-Apr;64(2):209-212. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_286_21. Epub 2022 Mar 24.
7
National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis.国家对世界卫生组织基本药物标准清单的适应和实施：定性证据综合分析。
PLoS Med. 2022 Mar 11;19(3):e1003944. doi: 10.1371/journal.pmed.1003944. eCollection 2022 Mar.
烟草使用和与烟草相关的行为 - 11 个国家，2008-2017 年。
MMWR Morb Mortal Wkly Rep. 2019 Oct 18;68(41):928-933. doi: 10.15585/mmwr.mm6841a1.
4
Opioid substitution therapy: Legal challenges.阿片类药物替代疗法：法律挑战。
Indian J Psychiatry. 2018 Jul-Sep;60(3):271-277. doi: 10.4103/psychiatry.IndianJPsychiatry_391_18.
5
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.1990 - 2016年195个国家和地区因酒精和药物使用所致的全球疾病负担：全球疾病负担研究2016的系统分析
Lancet Psychiatry. 2018 Dec;5(12):987-1012. doi: 10.1016/S2215-0366(18)30337-7. Epub 2018 Nov 1.
6
Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.药物辅助治疗对阿片类药物使用者死亡率的影响：系统评价和荟萃分析。
Mol Psychiatry. 2019 Dec;24(12):1868-1883. doi: 10.1038/s41380-018-0094-5. Epub 2018 Jun 22.
7
Tobacco use disorder and treatment: new challenges and opportunities.烟草使用障碍与治疗：新挑战与新机遇。
Dialogues Clin Neurosci. 2017 Sep;19(3):271-280. doi: 10.31887/DCNS.2017.19.3/dziedonis.
8
The journey of opioid substitution therapy in India: Achievements and challenges.印度阿片类药物替代疗法的历程：成就与挑战。
Indian J Psychiatry. 2017 Jan-Mar;59(1):39-45. doi: 10.4103/psychiatry.IndianJPsychiatry_37_17.
9
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.阿片类药物替代治疗期间及之后的死亡风险：队列研究的系统评价和荟萃分析
BMJ. 2017 Apr 26;357:j1550. doi: 10.1136/bmj.j1550.
10
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.1990-2015 年 195 个国家和地区的吸烟流行率和可归因疾病负担：来自 2015 年全球疾病负担研究的系统分析。
Lancet. 2017 May 13;389(10082):1885-1906. doi: 10.1016/S0140-6736(17)30819-X. Epub 2017 Apr 5.